[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584143":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":34,"responsibleParty":73,"collaborators":18,"id":75,"slug":76,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":77,"sex":83,"minAge":84,"maxAge":18,"enrollmentInfo":85,"targetDuration":18,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":97,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"Eodyne Systems SL","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental Group (RGS)","EXPERIMENTAL","The standardized intervention schedule consists of daily 20-30-minute training sessions with the RGSapp, conducted at home, including weekends, for 6 weeks. This intervention is provided in addition to the prescribed conventional therapy (Standard of Care, SoC).",[13],"Device: RGS",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","The control group participants will be assessed at Baseline (T0), Week 6\u002FEnd of Treatment (T2), and Follow-up at Week 14 (T3). The outcome measures will be the same as in the intervention group, including assessments of motor function, cognitive function, depression, activity participation, usability, and healthcare costs. No VR or AR-based interventions will be provided to the control group during the study period.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","RGS","The standardized intervention schedule consists of 20-30-minute daily training sessions (including weekends) for 6 weeks, in addition to the prescribed conventional therapy (Standard of Care, SoC). Each session includes 4 to 6 exercises, each lasting approximately 5 minutes. To promote variability and engagement, at least one exercise will be replaced every week based on the participant's progress. Participants are encouraged to train more than the prescribed duration if desired. The RGSapp training will take place at home, and patients will use a smartphone. An optional wearable device (smartwatch) will be used to remotely monitor the use of the paretic upper arm for the duration of the trial. Regular check-ins by clinicians will monitor adherence, adjust the intervention if needed, and ensure the participants' safety.",[9],[26,31],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"Santiago Brandi","CONTACT","34 931389642","contact@eodyne.com",{"name":32,"role":28,"phone":18,"phoneExt":18,"email":33},"Anna Mura","anna3.mura@gmail.com",[35,56],{"facility":36,"status":37,"city":38,"state":18,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RoNeuro Institute for Neurological Research and Diagnostics","RECRUITING","Cluj-Napoca","400354","Romania","RO",{"type":43,"coordinates":44},"Point",[45,46],23.6,46.76667,{"lat":46,"lon":45},[49,53],{"name":50,"role":28,"phone":51,"phoneExt":18,"email":52},"Fior-Dafin Mureşanu, Prof. Dr.","0374 46 22 22","roneuro.research@brainscience.ro",{"name":54,"role":55,"phone":18,"phoneExt":18,"email":18},"Fior-Dafin Mureşanu","PRINCIPAL_INVESTIGATOR",{"facility":57,"status":37,"city":58,"state":18,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Hospital Universitari Joan XXIII de Tarragona","Tarragona","43005","Spain","ES",{"type":43,"coordinates":63},[64,65],1.24544,41.11905,{"lat":65,"lon":64},[68,72],{"name":69,"role":28,"phone":70,"phoneExt":18,"email":71},"Rosa M San Segundo Mozo","977295800","rosamaria.sansegundo@urv.cat",{"name":69,"role":55,"phone":18,"phoneExt":18,"email":18},{"type":74,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100584143","personalised-health-motor-and-cognitive-assistance-system-for-rehabilitation-phrase-100584143",false,"NCT06885502","Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE)","Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE): A Randomized Clinical Trial","PHRASE-2024","Inclusion Criteria:\n\n* Patients presenting an ischemic or intracerebral haemorrhagic stroke, ≥ 3 months post-stroke.\n* Age \\> 18 years old\n* Moderate to mild proximal upper limb motor impairment Medical Research Council Scale (MRC \\>2).\n* ARAT: \\\u003C50, inclusive, to avoid ceiling effects while allowing room for improvement.\n* Able to sit on a chair or a wheelchair to interact with the RGS system.\n* Minimal experience with smartphone technology based on the clinician's opinion\n* Willing to participate and agree to comply with the trial scheme and procedures\n* Must sign an Informed Consent Form (ICF) indicating that they understand the purpose and the procedures of the study.\n\nExclusion Criteria:\n\n* Presence of a condition or abnormality that, in the opinion of the investigator, would compromise the safety of the patient or the quality of the data.\n* Severe cognitive capabilities that prevent the execution of the study, evaluated by the MoCA \\\u003C 19 or based on the clinician's opinion.\n* Pre-stroke history of upper limb motor disability.\n* Unable to use the RGS independently, according to the clinician's observations, and needing more support from a caregiver to use the RGS.","ALL","18 Years",{"count":86,"type":87},70,"ESTIMATED","INTERVENTIONAL",[90],"NA","This study is a multicentric randomized controlled trial evaluating the effectiveness of digital technology, specifically a smartphone with integrated VR-and AR-based intervention, for at-home rehabilitation after stroke. The study focuses on combined motor and cognitive training for patients in the late subacute and chronic phases post-stroke. The intervention is provided through the Rehabilitation Gaming System application RGSapp, a goal-oriented, first-person virtual reality (VR) and augmented reality (AR) mobile application for upper limb rehabilitation. A total of seventy participants will be randomly assigned (1:1 ratio) to either the RGSapp intervention or conventional therapy\u002Fstandard of care for six weeks. The primary outcome is motor function improvement (upper limb), assessed using the Action Research Arm Test (ARAT). Secondary outcomes include changes in cognitive function, depression, usability, adherence, validity of remote assessments, and healthcare costs.",[93,94,95,96],"Stroke","Stroke Rehabilitation","Chronic Stroke Patients","Post Stroke Recovery",[93,98,99,100,101,102,103,104,105,106,107],"ARAT","Motor rehabilitation","Stroke rehabilitation","Telemedicine","Virtual Reality (VR)","Augmented Reality (AR)","Cognitive rehabilitation","Rehabilitation at home","eHealth technology","upper limbs","2025-12-31",{"date":110,"type":111},"2026-01-06","ACTUAL",{"date":113,"type":111},"2025-02-21",{"date":115,"type":87},"2026-06-30",{"name":5,"class":6},2]